Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ACLC 2018
IASLC Asia Conference on Lung Cancer 2018
Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.
Presentation Date(s):- November 8 - 10, 2018
- Total Presentations: 137
-
+
Poster Session
- Type: Poster Session
- Track:
- Presentations: 90
- Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
-
+
P028 - A Novel Method for Detecting Surface PD-L1 on Circulating Tumor Cells in Peripheral Blood of Patients with SCLC
00:00 - 00:00 | Author(s): D. Zhao
- Abstract
Loading... -
+
P029 - Circulating MDSCs Derived from Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis
00:00 - 00:00 | Author(s): S. Lan
- Abstract
Loading... -
+
P107 - The Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Author(s): R. Zhong
- Abstract
Loading... -
+
P109 - Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC
00:00 - 00:00 | Author(s): L. Zhang
- Abstract
Loading... -
+
P111 - Circulating Tumor Cells Combined Myeloid Derived Suppressor Cells Predict Prognosis of Advanced Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Y. Liu
- Abstract
Loading... -
+
P112 - Significance of Low Expression of Tumor Associated Gene ki67 in Recurrence of Small Cell Lung Cancer
00:00 - 00:00 | Author(s): X. Zhang
- Abstract
Loading...
-
+
Best abstracts selected from submissions 5
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Crystal Ballroom 1
-
+
OA10 - CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
06:30 - 06:40 | Author(s): Y. Wu
- Abstract
Loading...
-
+
Best abstracts selected from submissions 7
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Jade Ballroom
-
+
OA14 - Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer (Slides Available)
22:30 - 22:40 | Author(s): Y. Cheng
- Abstract
Loading...
